EYETECH PHARMACEUTICALS, INC.

MACROGEN

Clinical medical reagents for use in gene therapy; pharmaceutical preparations for use in gene therapy; therapeutic compositions containing liposome reagents suitable for gene therapy; therapeutic compositions containing nucleic acid for gene therapy; pharmaceutical preparations containing nucleic acid for a system delivering genes to non-dividing cells for use in the treatment of viral and bacterial infections, cancer, HIV and AIDS related infections, leukemia and bodily conditions associated with impaired immunosystem;chemical compositions containing nucleic acids for use in the manufacture of pharmaceuticals and gene therapy preparations; chemical compositions containing nucleic acids for specific and industrial research use, enzymes for use in the manufacture of pharmaceuticals and gene therapy preparations, in vitro chemical reagents for scientific or medical research use for analysis, microorganisms, cell cultures, plasmids and cultures in microorganisms, deo-oxyribonucleic acids sequences, cloning vehicles and recombinant deo-oxyribonucleic acid variations thereof, all for in vivo use; and chemical compositions containing enzymes for use in the manufacture of pharmaceuticals and gene therapy preparation;scientific and medical research and development; medical services; genetic engineering services, biotechnology services, namely, research and development of new products in the field of biotechnology and gene therapy;